AATGF yields 4444.44% · JNJ yields 2.13%● Live data
📍 AATGF pulled ahead of the other in Year 1
Combined, AATGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AATGF + JNJ for your $10,000?
ATI Airtest Technologies Inc. manufactures and sells air testing equipment and related services in Canada and the United States. It offers WiFi and EnOcean transmitters; carbon dioxide (CO2) transmitters for control of ventilation in buildings; parking garage ventilation products comprising stand alone gas transmitters, combined sensor/controllers, and custom configured control systems for on/off and variable modulation of fan systems; indoor wall mount dew point transmitters, indoor humidity and temperature transmitters, outside air dew point for economizer control, humidity and dew point probes, and surface condensation switches. The company also provides industrial air velocity, HVAC airflow monitoring, and low airflow/laminar airflow monitoring products; handheld and portable devices; CO2 modules, air velocity probes, humidity elements, humidity and temperature measurement modules and probes, and humidity calibration; sensors/transmitters and ventilation controllers for measuring gases; industrial low dew point; industrial humidity and temp measurement; moisture in oil transmitters and portable moisture in oil measurement; and materials and tools to perform calibrations on various sensors. ATI Airtest Technologies Inc. was incorporated in 1996 and is headquartered in Delta, Canada.
Full AATGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.